Kamatani, Naoyuki
Kamitsuji, Shigeo
Akazawa, Yasuaki
Kido, Takashi
Akita, Masanori
Article History
Received: 30 June 2016
Revised: 10 July 2016
Accepted: 13 July 2016
First Online: 25 August 2016
Competing interests
: NK received employment fee from StaGen, fee as an advisor from SRL, fee as an advisor from Teijin Pharma and have stocks of StaGen and SmartMed. TK received employment fee from Riken Genesis, SK received employment fee from StaGen and MA received employment fee from MTI.
Free to read: This content has been made available to all.